China Clinical Development Summit to Feature over 50 Speakers from Global Pharma, Biotech, and CROs at Major Industry Conference & Exhibition on November 9-11 in Shanghai

, ChinaThe worldwide pharmaceutical, biotech, and clinical research organization (CRO) industries will gather in Shanghai this November 9-11 to attend the first major industry-focused conference covering China's booming clinical development industry.

"CHINA TRIALS 2008: Global Clinical Development Summit" will be the first and largest gathering ever of clinical experts from around the globe on the topic. Small and emerging biotech/pharma companies that have successfully outsourced trials to China will share strategies on selecting Chinese CROs as well as their experiences with the quality and acceptability of submitting the data to Western health authorities. Big pharma companies already in China will discuss strategies to refine and improve their clinical operations and interactions with the SFDA, China's health authority.

The 2008 Keynotes are: From "Made in China" to "Discovered in China"
Perry Nisen, M.D., Ph.D., Senior Vice President, Cancer Research, GlaxoSmithKline
Integrating China Into Global Clinical Development & Supporting Local China Registration
Joerg Moller, M.D., Senior Vice President- Head, Global Clinical Operations, Bayer
The Quality of Clinical Trials in China
Frank Jiang, M.D., Ph.D., Vice President, Global R&D/Head of China
 R&D, Sanofi-Aventis
CHINA TRIALS 2008 features an international speaking faculty of over 50 speakers from over 35 companies. Presenting companies from the pharma and biotech industry include Abbott, Amgen, AstraZeneca, Bayer, Biogen Idec, Bristol-Myers Squibb, Celgene, Chipscreen Biosciences, GlaxoSmithKline, Johnson & Johnson, Merck, Neuromed, Novartis, Novo Nordisk, Pfizer, Progen Pharmaceuticals, Sanofi-Aventis, Schering-Plough, Wyeth and many more.

All the major players from the CRO and clinical service provider industry will be in attendance including Quintiles, Covance, Parexel Apex, Paramax International, Excel Pharmastudies, Fountain Medical Development, Medidata Solutions, Zuellig Pharma, Venturepharm and more.

Some speaking opportunities remain and sponsorship/exhibition opportunities are still available. To explore these opportunities further, please contact the organizer Jon E. Liong at jon.liong@lycheegroup.com or call 1-732-917-0664.

CHINA TRIALS 2008 is organized by Lychee Group, LLC, a specialty media company focused exclusively on China's life sciences industry.

The attendee list, full agenda, and registration information can be found by visiting the conference website at www.chinatrialsevent.com.